Beneficial effects of phlorizin on diabetic nephropathy in diabetic db/db mice

Fei Pei1, Bao-Ying Li2, Zhen Zhang2

  • 1Department of Nephrology, Qi-Lu Hospital of Shandong University, Shandong Province 250012, People's Republic of China.

Abstract

Insights

Phlorizin treatment significantly reduced markers of kidney damage in diabetic mice, suggesting its potential as a novel therapy for diabetic nephropathy.

Area of Science:

  • Nephrology
  • Endocrinology
  • Proteomics

Background:

  • Diabetic nephropathy is a major complication of diabetes.
  • Understanding its mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the protective effects of phlorizin on diabetic nephropathy in db/db mice.
  • To explore the underlying molecular mechanisms of phlorizin's action.

Main Methods:

  • db/db diabetic mice and db/m control mice were treated with phlorizin or vehicle for 10 weeks.
  • iTRAQ quantitative proteomics identified differentially expressed proteins.
  • Ingenuity pathway analysis elucidated molecular pathways involved.

Main Results:

  • Phlorizin treatment attenuated increases in body weight, blood glucose, lipids, and kidney injury markers.
  • Histological analysis confirmed reduced renal injury in phlorizin-treated mice.
  • Phlorizin modulated protein expression related to renal disease, transport, and metabolism.

Conclusions:

  • Phlorizin demonstrates protective effects against diabetic nephropathy in mice.
  • Phlorizin may represent a promising therapeutic strategy for diabetic kidney disease.